{
  "patient_id": "sigir-201417",
  "rank_folder": "rank7_NCT01495806",
  "trial_info": {
    "trial_id": "NCT01495806",
    "title": "Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood",
    "brief_summary": "Background: Functional abdominal pain disorders (FAPD) are common in school-aged children; however, there is no reliable treatment.~Aim: To determine the efficacy and safety of glucomannan for treating FAPD in children.~Trial Setting: Department of Pediatrics, The Medical University of Warsaw.~Intervention: Patients will be enrolled in a double-blind, randomized controlled trial in which they will receive either glucomannan (10g) or placebo for 4 weeks.",
    "phase": "Phase 4",
    "drugs": [
      "Glucomannan",
      "placebo"
    ],
    "diseases": [
      "Functional Gastrointestinal Disorders"
    ],
    "enrollment": "90.0"
  },
  "inclusion_criteria": [
    "patient_has_finding_of_abdominal_pain_now",
    "patient_has_diagnosis_of_functional_abdominal_pain_syndrome_now",
    "patient_has_diagnosis_of_nonulcer_dyspepsia_now",
    "patient_has_diagnosis_of_abdominal_pain_now"
  ],
  "exclusion_criteria": [
    "patient_has_diagnosis_of_disorder_of_gastrointestinal_tract_now",
    "patient_has_diagnosis_of_chronic_disease_now",
    "patient_has_finding_of_growth_retardation_now"
  ]
}